Used in pharmaceutical research as a potential antidiabetic agent due to its structural similarity to thiazolidinedione derivatives, which are known to act as insulin sensitizers. It may target peroxisome proliferator-activated receptors (PPARs), particularly PPARγ, involved in glucose and lipid metabolism. Also investigated for anti-inflammatory and anticancer activities owing to its ability to modulate cellular signaling pathways. Its fluorinated aromatic moiety enhances metabolic stability and bioavailability, making it a candidate for drug development. Studied in vitro and in animal models for efficacy and toxicity profiling.